These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11159969

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
    Alonso de Velasco E, Verheul AF, van Steijn AM, Dekker HA, Feldman RG, Fernández IM, Kamerling JP, Vliegenthart JF, Verhoef J, Snippe H.
    Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
    [Abstract] [Full Text] [Related]

  • 4. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
    Sun Y, Hwang Yi, Nahm MH.
    Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
    [Abstract] [Full Text] [Related]

  • 5. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to Streptococcus pneumoniae Type 3 Capsular Polysaccharide.
    Kurbatova EA, Akhmatova NK, Zaytsev AE, Akhmatova EA, Egorova NB, Yastrebova NE, Sukhova EV, Yashunsky DV, Tsvetkov YE, Nifantiev NE.
    Front Immunol; 2020 Jan; 11():578019. PubMed ID: 33343566
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM, Lo Passo C, Scuderi A, Kolberg J, Baxendale H, Goldblatt D, Oggioni MR, Felici F, Andrew PW.
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 12. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X, Gray B, Chang S, Ward JI, Edwards KM, Nahm MH.
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes.
    McNeely T, Luo S, Manger W, Herber W, Schofield T, Tan C, Newman K, Sadoff J, Donnelly J, Cross A.
    Vaccine; 2006 Mar 10; 24(11):1941-8. PubMed ID: 16307833
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides.
    Parameswar AR, Park IH, Saksena R, Kovác P, Nahm MH, Demchenko AV.
    Chembiochem; 2009 Dec 14; 10(18):2893-9. PubMed ID: 19856369
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.